75 related articles for article (PubMed ID: 25621798)
1. Differential Association between Blood Glucose Levels and Nonrelapse Mortality after Allogeneic Hematopoietic Cell Transplantation Based on Presence or Absence of Preexisting Diabetes.
Rashid N; Gooley T; Boeckh M; Oshima MU; Chao JH; Hirsch IB; Mielcarek M
Transplant Cell Ther; 2024 Apr; 30(4):417.e1-417.e9. PubMed ID: 38242443
[TBL] [Abstract][Full Text] [Related]
2. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation.
Duncan CN; Brazauskas R; Huang J; Shaw BE; Majhail NS; Savani BN; Flowers MED; Battiwalla M; Beebe K; Dietz AC; Dvorak CC; Giller R; Jacobsohn DA; Kletzel M; Martin PL; Nemecek ER; Nuechterlein B; Talano JA; Pulsipher MA; Baker KS
Bone Marrow Transplant; 2018 Oct; 53(10):1278-1287. PubMed ID: 29581480
[TBL] [Abstract][Full Text] [Related]
3. Prediction of diabetes mellitus after kidney transplantation using patient-specific induced pluripotent stem cells.
Lim SW; Shin YJ; Cui S; Ko EJ; Chung BH; Yang CW
Kidney Res Clin Pract; 2024 Mar; 43(2):236-249. PubMed ID: 37448282
[TBL] [Abstract][Full Text] [Related]
4. A single high-resolution HLA mismatch has a similar adverse impact on the outcome of related hematopoietic stem cell transplantation as a single low-resolution HLA mismatch.
Fuji S; Kanda J; Kato S; Ikegame K; Morishima S; Miyamoto T; Hidaka M; Kubo K; Miyamura K; Tsudo M; Kobayashi H; Maesako Y; Eto T; Adachi S; Ichinohe T; Atsuta Y; Kanda Y;
Am J Hematol; 2015 Jul; 90(7):618-23. PubMed ID: 25850370
[TBL] [Abstract][Full Text] [Related]
5. Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study.
Ishida T; Jo T; Takemoto S; Suzushima H; Uozumi K; Yamamoto K; Uike N; Saburi Y; Nosaka K; Utsunomiya A; Tobinai K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Moriuchi Y; Imada K; Miyamoto T; Akinaga S; Tomonaga M; Ueda R
Br J Haematol; 2015 Jun; 169(5):672-82. PubMed ID: 25733162
[TBL] [Abstract][Full Text] [Related]
6. Influence of tacrolimus on podocyte injury inducted by angiotensin II.
Shengyou Y; Li Y; Zhihong H; Yuanyuan M
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):260-6. PubMed ID: 25650384
[TBL] [Abstract][Full Text] [Related]
7. Tacrolimus and the risk of solid cancers after liver transplant: a dose effect relationship.
Carenco C; Assenat E; Faure S; Duny Y; Danan G; Bismuth M; Herrero A; Jung B; Ursic-Bedoya J; Jaber S; Larrey D; Navarro F; Pageaux GP
Am J Transplant; 2015 Mar; 15(3):678-86. PubMed ID: 25648361
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model.
Mizokami D; Araki K; Tanaka N; Suzuki H; Tomifuji M; Yamashita T; Matsushita K; Shimada H; Shiotani A
Laryngoscope; 2015 Jun; 125(6):E210-5. PubMed ID: 25647147
[TBL] [Abstract][Full Text] [Related]
9. Characteristic features of tacrolimus-induced lung disease in rheumatoid arthritis patients.
Sasaki T; Nakamura W; Inokuma S; Matsubara E
Clin Rheumatol; 2016 Feb; 35(2):541-5. PubMed ID: 25644583
[TBL] [Abstract][Full Text] [Related]
10. ABO-incompatible liver transplantation for severe hepatitis B patients.
Zhou J; Ju W; Yuan X; Jiao X; Zhu X; Wang D; He X
Transpl Int; 2015 Jul; 28(7):793-9. PubMed ID: 25630359
[TBL] [Abstract][Full Text] [Related]
11. The impact of pre-transplantation diabetes and obesity on acute graft-versus-host disease, relapse and death after allogeneic hematopoietic cell transplantation: a study from the EBMT Transplant Complications Working Party.
Gjærde LK; Ruutu T; Peczynski C; Boreland W; Kröger N; Blaise D; Schroeder T; Peffault de Latour R; Gedde-Dahl T; Kulagin A; Sengeløv H; Yakoub-Agha I; Finke J; Eder M; Basak G; Moiseev I; Schoemans H; Koenecke C; Penack O; Perić Z
Bone Marrow Transplant; 2024 Feb; 59(2):255-263. PubMed ID: 38062242
[TBL] [Abstract][Full Text] [Related]
12. Nutritional support in allogeneic hematopoietic stem cell transplantation Asian perspective.
Fuji S; Cheng J; Yakushijin K; Wanitpongpun C
Blood Cell Ther; 2022 May; 5(2):54-60. PubMed ID: 36710949
[TBL] [Abstract][Full Text] [Related]
13. Association Between Body Composition and Development of Glucose Intolerance after Allogeneic Hematopoietic Cell Transplantation.
Bhandari R; Teh JB; He T; Peng K; Iukuridze A; Atencio L; Nakamura R; Mostoufi-Moab S; McCormack S; Lee K; Wong FL; Armenian SH
Cancer Epidemiol Biomarkers Prev; 2022 Nov; 31(11):2004-2010. PubMed ID: 35797113
[TBL] [Abstract][Full Text] [Related]
14. Malglycemia is associated with poor outcomes in pediatric and adolescent hematopoietic stem cell transplant patients.
Sopfe J; Pyle L; Keating AK; Campbell K; Liu AK; Wadwa RP; Verneris MR; Giller RH; Forlenza GP
Blood Adv; 2019 Feb; 3(3):350-359. PubMed ID: 30718242
[TBL] [Abstract][Full Text] [Related]
15. Nutritional status and hyperglycemia in the peritransplant period: a review of associations with parenteral nutrition and clinical outcomes.
Verdi Schumacher M; Moreira Faulhaber GA
Rev Bras Hematol Hemoter; 2017; 39(2):155-162. PubMed ID: 28577653
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of hyperglycemia on days 0-7 after allogeneic stem cell transplantation.
Kawajiri A; Fuji S; Tanaka Y; Kono C; Hirakawa T; Tanaka T; Ito R; Inoue Y; Okinaka K; Kurosawa S; Inamoto Y; Kim SW; Yamashita T; Fukuda T
Bone Marrow Transplant; 2017 Aug; 52(8):1156-1163. PubMed ID: 28319076
[TBL] [Abstract][Full Text] [Related]
17. How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT.
Fuji S; Rovó A; Ohashi K; Griffith M; Einsele H; Kapp M; Mohty M; Majhail NS; Engelhardt BG; Tichelli A; Savani BN
Bone Marrow Transplant; 2016 Aug; 51(8):1041-9. PubMed ID: 27042848
[TBL] [Abstract][Full Text] [Related]
18. Pre-transplant diabetes mellitus is a risk factor for non-relapse mortality, especially infection-related mortality, after allogeneic hematopoietic SCT.
Takano K; Fuji S; Uchida N; Ogawa H; Ohashi K; Eto T; Sakamaki H; Morishima Y; Kato K; Suzuki R; Fukuda T
Bone Marrow Transplant; 2015 Apr; 50(4):553-8. PubMed ID: 25621798
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
